Brian Roberts

Company: EpiVax

Job title: Director - Scientific & PreClinical Immunology

Seminars:

Immunogenicity Risk Assessment of Synthetic Peptide Drugs & Their Impurities 11:30 am

Peptide drugs serve vital therapeutic roles across medicine, with over 80 approved for human use, careful monitoring of impurities must be implemented FDA proposes of new pathways like the Abbreviated New Drug Application (ANDA) to hasten access to generic peptide drugs, emphasizing the need to monitor and disclose new impurities due to potential immunogenicity risks…Read more

day: Conference Day Two